Toward Better-Quality Compounded Drugs - An Update from the FDA.

N Engl J Med

From the Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD.

Published: December 2017

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMp1712905DOI Listing

Publication Analysis

Top Keywords

better-quality compounded
4
compounded drugs
4
drugs update
4
update fda
4
better-quality
1
drugs
1
update
1
fda
1

Similar Publications

Development and optimization of an in vitro release assay for evaluation of liposomal irinotecan formulation.

Int J Pharm

December 2024

Department of Pharmaceutical Sciences, University of Michigan, Ann Arbor, MI 48109, United States; Biointerfaces Institute, University of Michigan, Ann Arbor, MI 48109, United States. Electronic address:

Onivyde®, a pegylated irinotecan liposomal formulation, is approved by the USFDA for treating metastatic pancreatic adenocarcinoma. Despite the substantial interest in developing its generic versions, the unique structural and manufacturing complexities of liposomal formulations pose challenges. In this study, we address this gap by developing a robust in vitro release test (IVRT) using dialysis membrane techniques.

View Article and Find Full Text PDF

Two-dimensional sparse arrays and row-column arrays are both alternatives to 2-D fully addressed arrays with lower channel counts. Row-column arrays have recently demonstrated fast 3-D structural and flow imaging but commonly suffer from high grating lobes or require multiplexing to achieve better quality. Two-dimensional sparse arrays enable full-volume acquisitions for each transmit event, but plane-wave transmissions with them usually lack quality in terms of uniformity of wavefronts.

View Article and Find Full Text PDF

Study of diminutive granules as feed powders for manufacturability of high drug load minitablets.

Int J Pharm

May 2023

GEA-NUS Pharmaceutical Processing Research Laboratory, Department of Pharmacy, National University of Singapore, 18 Science Drive 4, Singapore 117543, Singapore. Electronic address:

The maximal amount of drug contained in a minitablet is limited. To reduce the total number of minitablets in a single dose, high drug load minitablets can be prepared from high drug load feed powders by various pharmaceutical processing techniques. Few researchers have however examined the influence of pharmaceutical processing techniques on the properties of high drug load feed powders, and consequently the manufacturability of high drug load minitablets.

View Article and Find Full Text PDF

Introduction: The management of NCDs is a growing challenge in low- and middle-income settings with the increasing prevalence and the associated demands that such conditions make on health systems. Fragile settings both exacerbate the risk of NCDs and undermine systems capacity. Lebanon is a setting where strategies to address rising NCDs burden have faced particularly acute contextual challenges.

View Article and Find Full Text PDF

For continuous pharmaceutical manufacturing of oral solid dosages, it is essential that product quality is measured inline. In this application, a continuous rotary tablet press is used. The goal is a model-based assessment of the quality of the blend in the feed frame to determine whether the concentration of the active pharmaceutical ingredient (API) will be within the prescribed limits.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!